Comparison Of Biologic Initiation And Health Care Costs Among Patients With Psoriasis Receiving Fixed-Dose Combination Halo-Betasol-Propionate 0.01%/Tazarotene 0.045% (Hp/Taz) Lotion Vs Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% (Cal/Bd) Foam

Leon Kircik,George Joseph,Patrick Gagnon-Sanschagrin,Brock Bumpass,Elizabeth Serra,Abby Jacobson,Annie Guerin,Brad P. Glick

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2021）

引用 0|浏览3

暂无评分

摘要

Background: Patients with psoriasis may benefit from more tolerable and effective topical therapy options with the potential to delay or prevent biologic initiation.

查看译文

关键词

psoriasis,health care costs,lotion,fixed-dose,halobetasol-propionate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要